SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (1060)7/28/1997 7:11:00 PM
From: per strandberg   of 6136
 
John,
Thanks for your info.
Just using the IMS data, I did some simple calculations that made me sell off most of my other stock and increasing my position in AGPH instead. I watched MRK and PFE lose $3-4 while AGPH was gaining a couple of points today.

Roche must be seeing how much money in the form of royalties they would save if they bought AGPH (Roche made about $3Bil last year).
If Roche makes a bid at e.g. $125, I guess that would be the end of all short interest.
However, I would prefer a small, more volatile AGPH to a steady rock like Roche.

Appreciating your work on this thread,
ps
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext